Invasive Lobular Breast Cancer as a Distinct Disease: Implications for Therapeutic Strategy
Abstract Invasive lobular carcinoma comprises 10–15% of all breast cancers and is increasingly recognised as a distinct and understudied disease compared with the predominant histological subtype, invasive ductal carcinoma. Hallmarks of invasive lobular carcinoma include E-cadherin loss, leading to...
Main Authors: | Jocelyn Luveta, Ruth M. Parks, David M. Heery, Kwok-Leung Cheung, Simon J. Johnston |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2019-12-01
|
Series: | Oncology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40487-019-00105-0 |
Similar Items
-
Association between PIK3CA activating mutations and outcomes in early-stage invasive lobular breast carcinoma treated with adjuvant systemic therapy
by: Ribnikar Domen, et al.
Published: (2023-06-01) -
A Comparison of the Clinicopathological Features, Metastasis Sites and Survival Outcomes of Invasive Lobular, Invasive Ductal and Mixed Invasive Ductal and Lobular Breast Carcinoma
by: Nüvit Duraker, et al.
Published: (2020-01-01) -
Invasif lobular carcinoma of the breast revealed by an inaugural medullary metastatsis
by: Mustapha Azzakhmam, et al.
Published: (2020-02-01) -
The Genomic Landscape of Lobular Breast Cancer
by: Amy E. McCart Reed, et al.
Published: (2021-04-01) -
Sentinel Lymph Node Metastasis in Invasive Lobular Carcinoma of the Breast
by: Hikmet Erhan Güven, et al.
Published: (2018-04-01)